Takeda Pharmaceutical Company LimitedTAK

Takeda Pharmaceutical, established in 1781 and based in Tokyo, is a global biopharmaceutical firm focused on the discovery, development, and commercialization of medicines. Its portfolio targets gastroenterology, rare diseases, plasma-derived therapies, oncology, and neuroscience, featuring brands like Entyvio, Takhzyro, and Vyvanse. Takeda maintains a vast international footprint and drives innovation through extensive strategic partnerships and licensing agreements with numerous research institutions and biotech firms.